Skip to main content

Articles

Page 3 of 327

  1. Early hormone-positive breast cancers typically have favorable outcomes, yet long-term surveillance is crucial due to the risk of late recurrences. While many studies associate MMP-11 expression with poor prog...

    Authors: Sébastien Molière, Massimo Lodi, Suzanne Leblanc, Anne Gressel, Carole Mathelin, Fabien Alpy, Marie-Pierre Chenard and Catherine Tomasetto
    Citation: BMC Cancer 2024 24:295
  2. Hepatic proteins, including albumin, prealbumin, and transferrin have been confirmed to be prognostic predictors in various cancers. This study aimed to comprehensively assess the prognostic value of these thr...

    Authors: Jia-Xin Huang, Xi Zhang, Meng Tang, Qi Zhang, Li Deng, Chun-Hua Song, Wei Li, Han-Ping Shi and Ming-Hua Cong
    Citation: BMC Cancer 2024 24:293
  3. PANoptosis is a specific type of inflammatory programmed cell death (PCD) modality that can be involved in three key modes of cellular programmed cell death-pyroptosis, apoptosis and necroptosis. We analyzed P...

    Authors: Yan Xu, Jingqi Hua, Hongliang Que, Tengyue Zeng, Quan Li, Junpeng Deng and Jianjun Xie
    Citation: BMC Cancer 2024 24:292
  4. For chronic hepatitis B virus (HBV) infection patients, increasing evidence has demonstrated the effectiveness of expanding the indications and applicable population for antiviral therapy. However, the expande...

    Authors: Yuxin Liang, Deyuan Zhong, Zilong Zhang, Yuhao Su, Su Yan, Chunyou Lai, Yutong Yao, Ying Shi, Xiaolun Huang and Jin Shang
    Citation: BMC Cancer 2024 24:291

    The Correction to this article has been published in BMC Cancer 2024 24:343

  5. Primary prostate cancer with metastasis has a poor prognosis, so assessing its risk of metastasis is essential.

    Authors: Qihuan Fu, Li Luo, Ruixia Hong, Hang Zhou, Xinzhi Xu, Yujie Feng, Kaifeng Huang, Yujie Wan, Ying Li, Jiaqi Gong, Xingyan Le, Xiu Liu, Na Wang, Jiangbei Yuan and Fang Li
    Citation: BMC Cancer 2024 24:290
  6. Prostate cancer screening is a crucial preventive element for improving the survival rates of prostate cancer. Therefore, our research objective was to investigate the effect of health belief model-based educa...

    Authors: Marwa Ibrahim Mahfouz Khalil, Ayat Ashour, Reem Said Shaala, Rasha Mahmoud Allam, Thoraya Mohamed Abdelaziz and Enas Fouad Sayed Mousa
    Citation: BMC Cancer 2024 24:289
  7. Although HPV prophylactic vaccines can provide effective immune protection against high-risk HPV infection, studies have shown that the protective effect provided by them would decrease with the increased age ...

    Authors: Yunwen Zhang, Sijing Liu, Mengdie Chen, Qian Ou, Sicheng Tian, Jing Tang, Zhiqun He, Zhaobin Chen and Chuan Wang
    Citation: BMC Cancer 2024 24:288
  8. Ampullary adenocarcinoma (AMPAC) is a rare malignancy, treated as pancreatic or intestinal cancer based on its histologic subtype. Little is known about the genomic features of Chinese patients with AMPAC.

    Authors: Zhang Dong, Wan Chong, Chen Chen, Li Qi, Li Mengke, Dou Minghui, Yuan Jiawei, Quan Longxi, Liu Hengchao, Jia Liu and Geng Zhimin
    Citation: BMC Cancer 2024 24:286
  9. Dermatofibrosarcoma protuberans (DFSP) has a high recurrence rate after resection. Because of the lack of specific manifestations, recurrent DFSP is easily misdiagnosed as post-resection scar. A few series hav...

    Authors: Xia Gong, Jia Li, Angang Ding, Jiaxin Zuo, Yamin Rao, Jun Chen and Ping Xiong
    Citation: BMC Cancer 2024 24:285
  10. This study aims to investigate the expression of UBQLN1 in lung cancer (LC) tissue and the diagnostic capability of autoantibody to UBQLN1 (anti-UBQLN1) in the detection of LC and the discrimination of pulmona...

    Authors: Yulin Wang, Songyun Ouyang, Man Liu, Qiufang Si, Xue Zhang, Xiuzhi Zhang, Jiaqi Li, Peng Wang, Hua Ye, Jianxiang Shi, Chunhua Song, Kaijuan Wang and Liping Dai
    Citation: BMC Cancer 2024 24:283
  11. Methylation of the promoters of SHOX2 and RASSF1A (LungMe®) exhibits promise as a potential molecular biomarker for diagnosing lung cancer. This study sought to assess the aberrant methylation of SHOX2 and RAS...

    Authors: Jian Liu, Tingting Bian, Bin She, Lei Liu, Hui Sun, Qing Zhang, Jun Zhu, Jianguo Zhang and Yifei Liu
    Citation: BMC Cancer 2024 24:282
  12. No widely used prognostic tool exists to demonstrate the benefit of oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX4) in patients with advanced hepatocellular carcinoma (HCC). We aimed to establish a progno...

    Authors: Jirapat Wonglhow, Patrapim Sunpaweravong, Chirawadee Sathitruangsak and Arunee Dechaphunkul
    Citation: BMC Cancer 2024 24:281
  13. The risk category of gastric gastrointestinal stromal tumors (GISTs) are closely related to the surgical method, the scope of resection, and the need for preoperative chemotherapy. We aimed to develop and vali...

    Authors: Jian Wang, Meihua Shao, Hongjie Hu, Wenbo Xiao, Guohua Cheng, Guangzhao Yang, Hongli Ji, Susu Yu, Jie Wan, Zongyu Xie and Maosheng Xu
    Citation: BMC Cancer 2024 24:280
  14. Triple-negative breast cancer (TNBC) is the most lethal subtype of breast cancer (BC). The circRNA-miRNA‒mRNA axis is a promising biomarker for the early diagnosis and prognosis of BC. However, the critical ci...

    Authors: Jie Ren, Wei Chen, Ya Zhou, Jianxiong Sun and Guoqin Jiang
    Citation: BMC Cancer 2024 24:278
  15. Adenosine monophosphate-activated protein kinase (AMPK) is associated with the development of liver hepatocellular carcinoma (LIHC). AMPKα2, an α2 subunit of AMPK, is encoded by PRKAA2, and functions as the catal...

    Authors: Yan Ouyang, Yan Gu, Xinhai Zhang, Ya Huang, Xianpeng Wei, Fuzhou Tang and Shichao Zhang
    Citation: BMC Cancer 2024 24:276
  16. Glioma recurrence, subsequent to maximal safe resection, remains a pivotal challenge. This study aimed to identify key clinical predictors influencing recurrence and develop predictive models to enhance neurol...

    Authors: Wanyu Qiao, Yi Wang, Chen Luo, Jinsong Wu, Guoyou Qin, Jie Zhang and Ye Yao
    Citation: BMC Cancer 2024 24:274
  17. Traditional nanodrug delivery systems have some limitations, such as eliciting immune responses and inaccuracy in targeting tumor microenvironments.

    Authors: Xuanbo Da, Bangping Cao, Jiantao Mo, Yukai Xiang, Hai Hu, Chen Qiu, Cheng Zhang, Beining Lv, Honglei Zhang, Chuanqi He and Yulong Yang
    Citation: BMC Cancer 2024 24:273
  18. Chemotherapy for metastatic pancreatic adenocarcinoma (PDAC) primarily relies on FOLFIRINOX (LV5FU- irinotecan – Oxaliplatine) and Gemcitabine – Nab-Paclitaxel in the first-line setting. However, second-lines ...

    Authors: A. Gueiderikh, A. Tarabay, M. Abdelouahab, C. Smolenschi, M. L. Tanguy, M. Valery, D. Malka, T. Pudlarz, A. Fuerea, V. Boige, A. Hollebecque, M. Ducreux and A. Boilève
    Citation: BMC Cancer 2024 24:272
  19. Previous studies have observed a link between immunophenotypes and lung cancer, both of which are closely associated with genetic factors. However, the causal relationship between them remains unclear.

    Authors: Ming Xu, Chengkai Li, Liyan Xiang, Siyue Chen, Lin Chen, Gongxia Ling, Yanqing Hu, Lan Yang, Xiang Yuan, Xiaodong Xia and Hailin Zhang
    Citation: BMC Cancer 2024 24:270
  20. Immune checkpoint inhibitors (ICIs) can lead to life-threatening pneumonitis, and pre-existing interstitial lung abnormalities (ILAs) are a risk factor for checkpoint inhibitor pneumonitis (CIP). However, the ...

    Authors: Xinyue Wang, Jinkun Zhao, Ting Mei, Wenting Liu, Xiuqiong Chen, Jingya Wang, Richeng Jiang, Zhaoxiang Ye and Dingzhi Huang
    Citation: BMC Cancer 2024 24:269
  21. Gemcitabine is a cornerstone drug for the treatment of all stages of pancreatic cancer and can prolong the survival of patients with pancreatic cancer, but resistance to gemcitabine in pancreatic cancer patien...

    Authors: Zhe Yang, Feiran Chen, Dafu Wei, Fengping Chen, Haixing Jiang and Shanyu Qin
    Citation: BMC Cancer 2024 24:268
  22. Significant advancements in improving ovarian cancer (OC) outcomes have been limited over the past decade. To predict prognosis and improve outcomes of OC, we plan to develop and validate a robust prognosis si...

    Authors: Meixuan Wu, Sijia Gu, Jiani Yang, Yaqian Zhao, Jindan Sheng, Shanshan Cheng, Shilin Xu, Yongsong Wu, Mingjun Ma, Xiaomei Luo, Hao Zhang, Yu Wang and Aimin Zhao
    Citation: BMC Cancer 2024 24:267
  23. Immune checkpoint inhibitors (ICIs) are commonly used in conjunction with chemotherapy to improve treatment outcomes for patients with gastric cancer. Since AFP could influence immunity by both inhibiting natu...

    Authors: Jingjing Zhang, Lei Wang, Shasha Zhang, Ruijie Cao, Yufei Zhao, Yue Zhao, Yanrong Song and Zhanjun Guo
    Citation: BMC Cancer 2024 24:266
  24. To evaluate the safety and effectiveness of computed tomography (CT)-guided radioactive 125I seeds brachytherapy (RISB) for lung oligometastases (LO) from colorectal cancer (CRC).

    Authors: Mengyao Song, Xueliang Zhou, Rongna Hou, Milan Sigdel, Yiming Liu, Chengzhi Zhang, Kaihao Xu, Xinwei Han and Dechao Jiao
    Citation: BMC Cancer 2024 24:265
  25. Patients with advanced gastrointestinal stromal tumors (GISTs) exhibiting an imatinib plasma trough concentration (IM Cmin) under 1100 ng/ml may show a reduced drug response rate, leading to the suggestion of mon...

    Authors: Pan Ran, Tao Tan, Jinjin Li, Hao Yang, Juan Li and Jun Zhang
    Citation: BMC Cancer 2024 24:264
  26. Whether Transanal drainage tubes (TDTs) placement reduces the occurrence of anastomotic leakage (AL) after rectal cancer (RC) surgery remains controversial. Most existing meta-analyses rely on retrospective st...

    Authors: Yating Liu, Xuhua Hu, Yu Huang, Xu Yin, Pengfei Zhang, Yaoguang Hao, Hongyan Li and Guiying Wang
    Citation: BMC Cancer 2024 24:263
  27. Advanced pancreatic cancer is one of the leading causes of cancer-related deaths. For patients with advanced pancreatic cancer, gemcitabine and nanoparticle albumin-binding paclitaxel (nabPTX) combination (GEM...

    Authors: Hiroo Imai, Yasuhiro Sakamoto, Shin Takahashi, Hiroyuki Shibata, Atsushi Sato, Kazunori Otsuka, Kenji Amagai, Masanobu Takahashi, Takuhiro Yamaguchi and Chikashi Ishioka
    Citation: BMC Cancer 2024 24:262
  28. Increasing evidence indicates that gut microbiota are closely related to prostate cancer. This study aims to assess the gut microbiota composition in patients with prostate cancer compared to healthy participa...

    Authors: Haotian Huang, Yang Liu, Zhi Wen, Caixia Chen, Chongjian Wang, Hongyuan Li and Xuesong Yang
    Citation: BMC Cancer 2024 24:261
  29. Primary tumor removal by cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma patients has been investigated in the context of various treatment regimens. Two randomized controlled trials i...

    Authors: Laura Iisager, Johanne Ahrenfeldt, Frede Donskov, Börje Ljungberg, Axel Bex, Lars Lund, Iben Lyskjær and Niels Fristrup
    Citation: BMC Cancer 2024 24:260
  30. For cervical cancer (CC), the implementation of preventive strategies has the potential to make cervical cancer occurrence and death largely avoidable. To better understand the factors possibly responsible for...

    Authors: Sara Bønløkke, Jan Blaakær, Torben Steiniche and Maria Iachina
    Citation: BMC Cancer 2024 24:259
  31. CCRT is presently the standard treatment for LA-NSCLC. RP is one of the main obstacles to the completion of thoracic radiation therapy, resulting in limited survival benefits in NSCLC patients. This research a...

    Authors: Kuifei Chen, Shuling Li, Meng Chen, Zhicheng Jin, Xuefeng Sun, Suna Zhou and Haihua Yang
    Citation: BMC Cancer 2024 24:257
  32. The low specificity of Thyroid Imaging Reporting and Data System (TI-RADS) for preoperative benign-malignant diagnosis leads to a large number of unnecessary biopsies. This study developed and validated a pred...

    Authors: Tingting Zheng, Lanyun Wang, Hao Wang, Lang Tang, Xiaoli Xie, Qingyin Fu, Pu-Yeh Wu and Bin Song
    Citation: BMC Cancer 2024 24:256
  33. This study assesses the metastasis rate of the key distal lymph nodes (KDLN) that are not routinely dissected in proximal gastrectomy, aiming to explore the oncological safety of proximal gastrectomy for upper...

    Authors: Yonghe Chen, Xiaojiang Chen, Yi Lin, Shenyan Zhang, Zhiwei Zhou and Junsheng Peng
    Citation: BMC Cancer 2024 24:255

    The Correction to this article has been published in BMC Cancer 2024 24:314

  34. The purpose of this study was to develop a functional clinical nomogram for predicting 8-year overall survival (OS) of patients with prostate cancer (PCa) primary based on peripheral lymphocyte.

    Authors: Jiayi Chen, Feng Yu, Ganyuan He, Wenke Hao and Wenxue Hu
    Citation: BMC Cancer 2024 24:254
  35. Cancer cachexia is associated with impaired functional and nutritional status and worse clinical outcomes. Global Leadership Initiative in Malnutrition (GLIM) consensus recommended the application of GLIM crit...

    Authors: Zong-Ze Li, Xia-Lin Yan, Zhao Zhang, Jiong-Lai Chen, Jiang-Yuan Li, Jing-Xia Bao, Jia-Tong Ru, Jia-Xin Wang, Xiao-Lei Chen, Xian Shen and Dong-Dong Huang
    Citation: BMC Cancer 2024 24:253
  36. Immune checkpoint inhibitor (ICI) or irinotecan-based chemotherapy is frequently used after failure of second-line paclitaxel plus ramucirumab treatment for patients with locally advanced unresectable or metas...

    Authors: Sung Hee Lim, Keun-Wook Lee, Jae-Joon Kim, Hyeon-Su Im, In-Ho Kim, Hye Sook Han, Dong-Hoe Koo, Jang Ho Cho, Chi Hoon Maeng, Min-Young Lee, Hyo Jin Lee, Jwa Hoon Kim, Sang Gon Park, Joo Young Jung, Seong-Hoon Shin, Ki Hyang Kim…
    Citation: BMC Cancer 2024 24:252
  37. The occurrence of surgical site infection (SSI) after pancreaticoduodenectomy (PD) is still relatively high. The aim of this retrospective study is to evaluate the efficacy of piperacillin-tazobactam as periop...

    Authors: Yifei Yang, Jianjie Sheng, Zhenghua Cai, Linxi Zhu, Chenglin Lu, Liang Mao, Yudong Qiu and Xu Fu
    Citation: BMC Cancer 2024 24:251
  38. Increasing evidence has showed that inflammatory biomarkers, including neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and fibrinogen can be used as predictors in the prognosis of esop...

    Authors: Yuchong Yang, Hui Tan, Yao Lu, Jipeng Mei, Mengqi Zhang, Ming Bai, Xia Wang, Shaohua Ge, Tao Ning, Le Zhang, Zhi Ji, Jingjing Duan, Yansha Sun, Feixue Wang, Rui Liu, Hongli Li…
    Citation: BMC Cancer 2024 24:249
  39. Lung cancer is a leading cause of cancer-related mortality worldwide, and effective therapies are limited. Lung cancer is a leading cause of cancer-related mortality worldwide with limited effective therapy. S...

    Authors: Huang-Chi Chen, Chia-Yu Kuo, Yu Chang, Dong-Lin Tsai, Mei-Hsuan Lee, Jui-Ying Lee, Hui-Ming Lee and Yu-Chieh Su
    Citation: BMC Cancer 2024 24:248
  40. Limited information is available for guiding the management of upper urinary tract (UUT) urothelial carcinoma with squamous differentiation (UC-SqD). We did not even know about the difference between pure uro...

    Authors: Li-Hua Huang, Chuan-Shu Chen, Jian-Ri Li, Kun-Yuan Chiu, Shian-Shiang Wang, Cheng-Kuang Yang, Chen-Li Cheng, Chi-Chien Lin and Yen-Chuan Ou
    Citation: BMC Cancer 2024 24:247
  41. Artificial intelligence (AI)-assisted clinical trial screening is a promising prospect, although previous matching systems were developed in English, and relevant studies have only been conducted in Western co...

    Authors: Kunyuan Wang, Hao Cui, Yun Zhu, Xiaoyun Hu, Chang Hong, Yabing Guo, Lingyao An, Qi Zhang and Li Liu
    Citation: BMC Cancer 2024 24:246
  42. Esophageal squamous cell carcinoma (ESCC) is a high-risk malignant tumor that has been reported in China. Some studies indicate that gut microbiota disorders can affect the occurrence and development of ESCC, ...

    Authors: Xingqiang Huang, Xueyi Chen, Guowei Wan, Dandan Yang, Dongqiang Zhu, Linqian Jia and Jinping Zheng
    Citation: BMC Cancer 2024 24:245

Featured videos

View featured videos from across the BMC-series journals